Select Page

The latest report on “Needle Free Drug Delivery Devices Market (Technology – Jet Injectors, Inhaler Technology, Transdermal Patch Technology, Novel Needle-free Technologies, and Oral Drug Delivery System; Application – Vaccine Delivery, Pain Management, Insulin Delivery for Diabetes, Pediatric Injections, and Other Applications): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025.” The global needle free drug delivery devices market is projected to grow at a CAGR of 10.3% over the forecast period of 2019-2025.

Ask for Sample Copy of Research Report with Table of Content @

The growing incidences of chronic diseases like HIV AIDS, Dengue, and Hepatitis are the major factors that are driving the growth of the global needle free drug delivery devices market across the globe. According to the World Health Organization, HIV continues to be a major global public health issue, having claimed more than 32 million lives so far. Nearly, 770 000 people died from HIV-related causes across the globe in 2018. On the other hand, increasing demand for regular administration of the drug in diseases like hepatitis and dengue also plays a key role in the growth of the global market.

Furthermore, the occurrence of well-developed healthcare facilities and extensive research and development costs by government administrations and pharmaceutical companies for diabetes and chronic pain organization are also fueling the growth of the needle free drug delivery devices market. However, high initial costs of needle free drug delivery devices may restrain the growth of the market. Moreover, technological advancements in terms of pain-free drug transportation and self-administration create an opportunity for the growth of the global needle free drug delivery devices market in the upcoming years.

North America is Leading the Global Needle Free Drug Delivery Devices Market

In terms of region, the global needle free drug delivery devices market is categorized into North America, Europe, Asia Pacific and the Rest of the World. Among all regions, North America is leading the global needle free drug delivery devices market due to increasing incidences of chronic diseases. Furthermore, high awareness relating to novel drug delivery systems among the patient base also plays a vital role in the growth of the market in the North American region. The Asia Pacific is expected to grow at a beneficial rate during the forecast period. This is attributed to the increasing elderly population, the growing occurrence of diabetes in developing countries such as India and China. According to the International Diabetes Federation, nearly 7.2 billion individuals are suffering from diabetes in India and around 11.4 billion people are suffering from diabetes in China.

Segment Covered

The report on global needle free drug delivery devices market covers segments such as technology, and application. On the basis of technology, the sub-markets include jet injectors, inhaler technology, transdermal patch technology, novel needle-free technologies, and oral drug delivery system. On the basis of application, the sub-markets include vaccine delivery, pain management, insulin delivery for diabetes, pediatric injections, and other applications.

Browse Detailed TOC and Description of this Exclusive Report@

Companies Profiled:

The report provides profiles of the companies in the market such as 3M, AkraDermojet Inc, Antares Pharma Inc., Bayer AG, Bioject Medical Technologies, Inc., GlaxoSmithKline plc, Glide Pharmaceutical Technologies Ltd., InjexPharma AG, Medtronic, Inc., Zogenix, Inc., and other companies.

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the needle free drug delivery devices.

=> Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.